Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 AND SODIUM CHLORIDE 0 3 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 AND SODIUM CHLORIDE 0 3 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN PLASTIC CONTAINER.
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of carbohydrates to increase blood glucose levels, and sodium chloride provides electrolytes to maintain fluid and electrolyte balance. It acts as a source of calories and water for hydration.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Intravenous infusion; rate and volume determined by patient's fluid and electrolyte requirements, typically 100-200 mL/hour for maintenance in adults.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
None Documented
None Documented
Not applicable as dextrose is rapidly metabolized; sodium and chloride are electrolytes with homeostatic regulation. No terminal elimination half-life defined.
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Renal: Dextrose is completely metabolized to CO2 and water; sodium and chloride are excreted renally. Essentially no biliary/fecal elimination.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Category A/B
Category C
Electrolyte
Electrolyte